Saturday, April 27, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Ultrasound and Other Vaccine Delivery Systems Coming Soon

vaccination by ultrasound

Vaccinations are often associated with needles and syringes. But that may change significantly in the near future as the growth trajectory for the Global Needle-Free Injectors industry is anticipated to surge in the next decade.1

The pharmaceutical industry has continued to receive large amounts of funding from the Bill & Melinda Gates Foundation, as well as United States government health agencies to develop innovative vaccine administration techniques without the use of a syringe, such as delivery through ultrasound. Last month, the Gates Foundation, the National Institutes of Health (NIH), and the Department of Defense (DoD) awarded a total of more than $31 million in grants to various pharmaceutical companies to advance the manufacturing of needle free vaccine systems.2

COVID “Reinvigorated” Interest in More Efficient Vaccine Delivery

Scientists have been developing needle-free vaccines known as microarray patches (MAPs) for decades, but the COVID-19 pandemic reinvigorated and fueled the interest.2

The driving force behind the massive growth is a demand for delivery systems that are faster and more efficient. Advocates for these systems believe they will help lower barriers to access and help overcome logistical obstacles hindering vaccine deployment. GAVI, the Vaccine Alliance, an organization partially founded by the Gates Foundation, which works to increase access to vaccines in poor countries, states that MAPs will ensure that “these lifesaving interventions reach everyone, everywhere, as quickly as possible” and could also ensure rapid deployment in the event of future epidemics or pandemics.1

Pfizer a Key Player in Needle-Free Technology Development

The U.S. has a significant financial stake in the Global Needle Free Injectors industry, with Germany, Japan, and China also accelerating development of needle free technologies. Key pharmaceutical companies in the needle free vaccine market include U.S.-based companies Pfizer, Inc. and Antares Pharma, Inc.; German company Gerresheimer AG; Australian company CSL Limited, and others.1

Vaccines Delivered Via Ultrasound

Earlier this month, news outlets reported that researchers at Oxford University successfully developed a needle-free vaccine delivered through the skin via ultrasound. Lead researcher Darcy Dunn-Lawless and his colleagues mixed vaccine molecules with tiny, cup-shaped molecules made of protein then applied the liquid mixture to the skin of mice. The ultrasound was able to push the mixture into the upper layers of the skin.

The researchers found that, while the ultrasound method delivered 700 times fewer vaccine molecules than needles, the animals produced more antibodies. The technology is still being developed.3

Other needle-free vaccine systems include a nasal patch;4 a gas-based system which delivers via a puff of air;5 edible vaccines;6 and a jet injector, which uses “a high-pressure, narrow stream of fluid to penetrate the skin.” The jet injector is already approved for use in the AFLURIA Quadrivalent flu vaccine.7

In August of 2022, the University of Adelaide in Australia began a human trial of delivering an Omicron COVID booster shot using a Jetstream system.1

The needle-free vaccine market is anticipated to surge at a 12 percent compound annual growth rate over the next decade and reach a valuation of $42.79 billion.1


If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.

Click here to view References:

1 Sawlani N. Global Needle-Free Injectors Industry Set to Skyrocket with a 12% CAGR, Reaching US$ 42.79 Billion by 2032. PharmiWeb.com Nov. 9, 2023.
2 Cáceres M. “Needle-Free” Vaccines Pushed by Gates Foundation, U.S. Government. The Vaccine Reaction Dec. 4, 2023.
3 Callaghan K. Ultrasound can push vaccines into the body without needles. NewScientist Dec. 4, 2023.
4 Urban J. New needle-free nasal vaccine shows promise for COVID-19. American Society for Microbiology July 28, 2022.
5 Carpenter K. A puff of air could deliver vaccines needle free. ScienceNews Explores Sept. 18, 2023.
6 Dutton G. On the horizon, needle-free vaccines could offer better protection and access. BioSpace Oct. 25, 2022.
7 U.S. Centers for Disease Control and Prevention.  Flu vaccination by jet injector. Aug. 25, 2023.
8 Wayt T. CDC bought cellphone data to track vaccination, lockdown compliance: report. New York Post May 4, 2022.

11 Responses

  1. Doesn’t matter what form; whether needle free, aerosol, injections or whatever else they come up with, I’m not interested.

  2. I don’t know about anyone else, but this makes me even more cautious. Read between the lines. Nothing good comes from the Bill and Linda Gates Foundation. The Department of Defense is funding this? Since when does the Dod play a part in vaccinating people? Oh, that’s right. Since Covid was declared! The NIH has proven they are anything but that. They are not for health. And if Pfizer is a key player in anything, you can bet it’s DIRTY. They are all about themselves, greedy SOB’s. They hid the real results of their trials from citizens so they wouldn’t be questioned about its efficacy.

    The farther from vaccines I get, the healthier I become. So I am alarmed about these needle-less systems. They want an easier way to get ALL of us with their bio-weapons/warfare/vaccines.

  3. This frightens me. These methods of delivering vaccines can be covertly employed without the person being aware of it. They don’t necessarily need our consent because the way it’s going if they all feel that we need to have it they’re going to ensure that we do. And when I say they I mean people that do not have our best interests at heart although they’re packaging it as such. I never took the Covid vaccine and I never will. I stay away from the flu vaccine or anything else that’s injected that’s supposedly good for me except maybe a vitamin C shot. I’m healthy and I’m 68 and I don’t have myocarditis.

  4. https://www.sciencedirect.com/science/article/pii/S027869152200206X

    The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA from cellular defenses and promote a longer biological half-life and high production of spike protein. However, the immune response to the vaccine is very different from that to a SARS-CoV-2 infection. In this paper, we present evidence that vaccination induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. Immune cells that have taken up the vaccine nanoparticles release into circulation large numbers of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in regulatory control of protein synthesis and cancer surveillance. These disturbances potentially have a causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive immunity, impaired DNA damage response and tumorigenesis. We show evidence from the VAERS database supporting our hypothesis. We believe a comprehensive risk/benefit assessment of the mRNA vaccines questions them as positive contributors to public health.

  5. Never believe any organization backed by “big money” especially from any Bill and Melinda Gates organizations. Those two are piss ants from hell.

  6. So … at least one study[1] found that prenatal ultrasound depth is associated with development of autism spectrum disorder, so what is they possibility of neurological side effects of vaccination delivered by ultrasound?

    [1] Association of Prenatal Ultrasonography and Autism Spectrum Disorder
    JAMA Pediatr. 2018 Apr; 172(4): 336–344. Published online 2018 Feb 12. doi: 10.1001/jamapediatrics.2017.5634
    PMCID: PMC5875374PMID: 29435580
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875374/

Leave a Reply

Your email address will not be published. Required fields are marked *

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search